-
Mashup Score: 4
Purpose of Review To provide an updated review of bempedoic acid’s clinical application in lowering LDL-C in the setting of statin intolerance and the recent findings in the CLEAR Outcomes trial as well as summarize and synthesize the current state of knowledge regarding bempedoic acid while providing an in-depth analysis of the drug’s pharmacological properties, mechanism of action, clinical…
Source: SpringerLinkCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
No attenuation of vascular risk reduction between younger and older statin users
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
According to a new study in #JACC, the #cvPrev benefits of lowering LDL #Cholesterol were similar for #Statin users younger and older than 70 years of age. https://t.co/VimLteTSqf @medpagetoday @nicolejlou
-
-
Mashup Score: 7Statins for primary prevention provide similar protection among older vs. younger adults - 7 month(s) ago
Older individuals appeared to derive similar magnitude of LDL lowering and CV risk reduction from statin therapy initiation vs. younger patients, according to data from a large Danish study.“Use of lipid-lowering therapy to reduce LDL cholesterol constitutes the main pharmacologic intervention strategy for both primary and secondary prevention of atherosclerotic CVD. Evidence from clinical
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “Our results ... may contribute to informing future guideline recommendations and clinician-patient discussion on the clinical benefit observed from lowering LDL cholesterol among older individuals for primary prevention” @ACCinTouch #Cardiotwitter https://t.co/BlUampUysZ
-
Patients 70 years of age or older have similar LDL lowering w/ #Statin therapy compared to younger patients, a new #JACC study suggests. https://t.co/Krf9BZM07E @CardiologyToday #Cholesterol
-
-
Mashup Score: 1
We are grateful to these distinguished faculty who contributed to this collection: Michael D. Shapiro, DO, FACC (Chair) Charles German, MD, MS Christie M. Ballantyne, MD, FACC Pam Taub, MD, FACC Raul D. Santos MD, PhD, MSc Salim S. Virani, MD, FACC Sarah de Ferranti MD, MPH
Source: learn.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
This #Cholesterol Education month, 🔎 ACC's 💻 course, #FamilialHypercholesterolemia: Improving Detection to Accelerate Treatment, which features an infographic, expert analysis, a three-part CardiaCast podcast series & quick-tip 📹. ➡️ https://t.co/bPzupFYxpz #KnowFH #ACCEd https://t.co/vt9YyUpRrh
-
-
Mashup Score: 4Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell–mediated inflammation in the skin - 8 month(s) ago
CD4+ T cells limit pathogenic bystander T cell expansion by suppressing cholesterol biosynthesis via secreted 25-hydroxycholesterol.
Source: www.science.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
Researchers from @KeioGlobal @NIH_NIAMS discovered a pathway involving #cholesterol that represses excessive T cell responses. In mouse models of #dermatitis, blocking this pathway worsened the autoimmune disease. 📄: https://t.co/ZnKs0fMN57 #WeekendReads https://t.co/noxnVB3NZs
-
-
Mashup Score: 0LDL-C and Cardiovascular Disease Risk - 8 month(s) ago
Expert cardiologists discuss the various lines of evidence that have shown a causative effect of LDL-C in the development of atherosclerosis.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
We've launched our latest video series on #dyslipidemia! In this series, experts @ErinMichos @payalkohlimd @kcferdmd @CBallantyneMD and @DrMaryMcGowan discuss ASCVD prevention and new data in #cholesterol management. https://t.co/pII9lpGsTD https://t.co/I7BSK50w2P
-
-
Mashup Score: 0
Can you treat high cholesterol in these challenging patient scenarios?
Source: www.medscape.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
✅ Can you treat high #cholesterol in these challenging patient scenarios? #CME #CardioX #MedEd 📍 https://t.co/o1uiQ6kEaz https://t.co/cydh4OwyRW
-
-
Mashup Score: 11High Cholesterol | CardioSmart – American College of Cardiology - 8 month(s) ago
Esperion Therapeutics, Inc.
Source: www.cardiosmart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Did you know about 2 in 5 adults in the U.S. have high #cholesterol? September is National Cholesterol Education Month & #CardioSmart is the perfect resource for your patients to get free education on cholesterol & other conditions! https://t.co/l10UQtQgI7 https://t.co/lWD3iI7An3
-
-
Mashup Score: 13Nonstatin Strategies and Therapies for LDL-C Lowering Pocket Guide - American College of Cardiology - 8 month(s) ago
Nonstatin Strategies and Therapies for LDL-C Lowering Pocket Guide
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ACC created a pocket guide on nonstatin strategies & therapies for lowering LDL-C #cholesterol. This tool guides clinician decision-making on the optimization of statin therapies in accordance w/ clinical guidelines & practical guidance. https://t.co/2B4gXWtzVS https://t.co/fKXL8hkNjN
-
-
Mashup Score: 6Home - American College of Cardiology - 8 month(s) ago
The American College of Cardiology, a 49,000-member nonprofit medical society, is dedicated to enhancing the lives of cardiovascular patients through continuous quality improvement, patient-centered care, payment innovation and professionalism.
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen: Don't miss the CLEAR Outcomes trial update on https://t.co/HPWASvOFR5 with coverage from #ESCCongress 2023. https://t.co/A4PPBONJuj #CardioTwitter https://t.co/3GUPHgWgol
-
👇 Check it out! Here’s an up-to-date review on Bempedoic acid and all the latest trials: https://t.co/iF1svkaDdd. #cholesterol #LDL #bempedoicacid #statin #myalgias #CLEAROutcomes #prevention #cardiology